Published in J Hepatobiliary Pancreat Surg on November 30, 2006
Endoscopic management of biliary strictures after liver transplantation. World J Gastroenterol (2009) 1.11
Ischemia-Reperfusion Injury and Ischemic-Type Biliary Lesions following Liver Transplantation. J Transplant (2012) 1.09
Biliary complications following orthotopic liver transplantation: a 10-year audit. HPB (Oxford) (2011) 0.99
The protective role of CD59 and pathogenic role of complement in hepatic ischemia and reperfusion injury. Am J Pathol (2011) 0.90
Dipeptidylpeptidase--IV, a key enzyme for the degradation of incretins and neuropeptides: activity and expression in the liver of lean and obese rats. Eur J Histochem (2012) 0.88
Autophagy and liver ischemia-reperfusion injury. Biomed Res Int (2015) 0.88
Effects of warm ischemia time on biliary injury in rat liver transplantation. World J Gastroenterol (2012) 0.87
The current diagnosis and treatment of benign biliary stricture. Surg Today (2012) 0.86
Histological examination and evaluation of donor bile ducts received during orthotopic liver transplantation--a morphological clue to ischemic-type biliary lesion? Virchows Arch (2012) 0.84
Management of biliary complications following living donor liver transplantation--a single center experience. Langenbecks Arch Surg (2009) 0.84
Establishment of a rat liver transplantation model with prolonged biliary warm ischemia time. World J Gastroenterol (2012) 0.82
Orthotopic liver transplantation and what to do during follow-up: recommendations for the practitioner. Nat Clin Pract Gastroenterol Hepatol (2008) 0.81
Current diagnosis and treatment of benign biliary strictures after living donor liver transplantation. World J Gastroenterol (2016) 0.81
[Current aspects of liver allograft pathology]. Pathologe (2011) 0.79
Benign biliary strictures: current endoscopic management. Nat Rev Gastroenterol Hepatol (2011) 0.79
Growing a whole porcine liver organ ex situ for six hours without red blood cells or hemoglobin. Am J Transl Res (2016) 0.78
Donation after cardio-circulatory death liver transplantation. World J Gastroenterol (2012) 0.78
Altered alkaline phosphatase activity in obese Zucker rats liver respect to lean Zucker and Wistar rats discussed in terms of all putative roles ascribed to the enzyme. Eur J Histochem (2011) 0.78
Chemokines in chronic liver allograft dysfunction pathogenesis and potential therapeutic targets. Clin Dev Immunol (2013) 0.78
New diagnosis and therapy model for ischemic-type biliary lesions following liver transplantation--a retrospective cohort study. PLoS One (2014) 0.77
Establishment of an animal model of ischemic type intrahepatic biliary lesion in rabbits. World J Gastroenterol (2009) 0.77
Urokinase perfusion prevents intrahepatic ischemic-type biliary lesion in donor livers. World J Gastroenterol (2009) 0.76
How do we manage post-OLT redundant bile duct? World J Gastroenterol (2013) 0.76
Warm ischemia may damage peribiliary vascular plexus during DCD liver transplantation. Int J Clin Exp Med (2015) 0.75
Living donor liver transplantation using dual grafts: ultrasonographic evaluation. World J Gastroenterol (2010) 0.75
Biliary Cast Syndrome: Hepatic Artery Resistance Index, Pathological Changes, Morphology and Endoscopic Therapy. Chin Med J (Engl) (2015) 0.75
Iatrogenic-related transplant injuries: the role of the interventional radiologist. Semin Intervent Radiol (2015) 0.75
Beyond poiseuille: preservation fluid flow in an experimental model. J Transplant (2013) 0.75
[Histopathology in liver transplantation]. Pathologe (2008) 0.75
Cyst fluid analysis in the differential diagnosis of pancreatic cystic lesions: a pooled analysis. Gastrointest Endosc (2005) 3.28
Fibrin sealant for prevention of resection surface-related complications after liver resection: a randomized controlled trial. Ann Surg (2012) 3.28
The impact of intraoperative transfusion of platelets and red blood cells on survival after liver transplantation. Anesth Analg (2008) 2.45
Hemostasis and thrombosis in patients with liver disease: the ups and downs. J Hepatol (2010) 2.41
Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease. Liver Transpl (2005) 2.35
Chronic hepatitis E virus infection in liver transplant recipients. Liver Transpl (2008) 2.30
Management of nonneoplastic portal vein thrombosis in the setting of liver transplantation: a systematic review. Transplantation (2012) 2.26
Lectin complement pathway gene profile of donor and recipient determine the risk of bacterial infections after orthotopic liver transplantation. Hepatology (2010) 2.25
Shared decision making in transplantation: how patients see their role in the decision process of accepting a donor liver. Liver Transpl (2014) 2.01
Results of pancreaticoduodenectomy in patients with periampullary adenocarcinoma: perineural growth more important prognostic factor than tumor localization. Ann Surg (2008) 1.79
Report of the Paris consensus meeting on expanded criteria donors in liver transplantation. Liver Transpl (2008) 1.75
Platelet transfusion during liver transplantation is associated with increased postoperative mortality due to acute lung injury. Anesth Analg (2009) 1.70
Long-term results of urgent revascularization for hepatic artery thrombosis after pediatric liver transplantation. Liver Transpl (2010) 1.68
Normal to increased thrombin generation in patients undergoing liver transplantation despite prolonged conventional coagulation tests. J Hepatol (2009) 1.65
Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission. J Hepatol (2012) 1.58
Who should get a liver graft? J Hepatol (2009) 1.56
Immediate postoperative low platelet count is associated with delayed liver function recovery after partial liver resection. Ann Surg (2010) 1.50
Interlaboratory variability in assessment of the model of end-stage liver disease score. Liver Int (2008) 1.50
Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences. Blood (2010) 1.49
Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci. Nat Genet (2010) 1.43
Dearterialization of the liver causes intrahepatic cholestasis due to reduced bile transporter expression. Transplantation (2008) 1.43
Liver transplantation for unresectable hepatocellular carcinoma in normal livers. J Hepatol (2012) 1.42
The hemostatic status of pediatric recipients of adult liver grafts suggests that plasma levels of hemostatic proteins are not regulated by the liver. Blood (2010) 1.40
Anastomotic biliary strictures after liver transplantation: causes and consequences. Liver Transpl (2006) 1.32
Biliary complications after liver transplantation: a review. Scand J Gastroenterol Suppl (2006) 1.31
Impact of blood loss on outcome after liver resection. Dig Surg (2007) 1.28
Prevalence of hepatitis E virus infection in liver transplant recipients. Liver Transpl (2009) 1.21
Matrix metalloproteinase 2 genotype is associated with nonanastomotic biliary strictures after orthotopic liver transplantation. Liver Int (2011) 1.15
Nonanastomotic biliary strictures after liver transplantation, part 2: Management, outcome, and risk factors for disease progression. Liver Transpl (2007) 1.12
Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9. Hepatology (2011) 1.09
Treatment of chronic hepatitis E in liver transplant recipients with pegylated interferon alpha-2b. Liver Transpl (2010) 1.09
The combination of primary sclerosing cholangitis and CCR5-Δ32 in recipients is strongly associated with the development of nonanastomotic biliary strictures after liver transplantation. Liver Int (2010) 1.08
Recombinant factor VIIa in patients with coagulopathy secondary to anticoagulant therapy, cirrhosis, or severe traumatic injury: review of safety profile. Transfusion (2006) 1.07
Bleeding in liver surgery: prevention and treatment. Clin Liver Dis (2009) 1.06
Nonanastomotic biliary strictures after liver transplantation, part 1: Radiological features and risk factors for early vs. late presentation. Liver Transpl (2007) 1.03
Surgical treatment of renal cell cancer liver metastases: a population-based study. Ann Surg Oncol (2011) 1.02
Towards a rational use of low-molecular-weight heparin in patients with cirrhosis. Liver Int (2011) 1.02
Excellent survival after liver transplantation for isolated polycystic liver disease: an European Liver Transplant Registry study. Transpl Int (2011) 1.02
Role of fibrin sealants in liver surgery. Dig Surg (2012) 1.01
Platelets in liver transplantation: friend or foe? Liver Transpl (2008) 0.99
Validation of the donor risk index in orthotopic liver transplantation within the Eurotransplant region. Liver Transpl (2012) 0.99
Protection of bile ducts in liver transplantation: looking beyond ischemia. Transplantation (2011) 0.98
Expression of heme oxygenase-1 in human livers before transplantation correlates with graft injury and function after transplantation. Am J Transplant (2005) 0.98
Smoking behavior in liver transplant recipients. Liver Transpl (2009) 0.97
Minimizing blood loss in liver transplantation: progress through research and evolution of techniques. Dig Surg (2005) 0.96
Topical haemostatic agents in liver surgery: do we need them? HPB (Oxford) (2009) 0.95
Liver transplantation with preservation of the inferior vena cava. A comparison of conventional and piggyback techniques in adults. Clin Transplant (2004) 0.95
An unbalance between von Willebrand factor and ADAMTS13 in acute liver failure: implications for hemostasis and clinical outcome. Hepatology (2013) 0.94
A benefit-risk review of systemic haemostatic agents: part 1: in major surgery. Drug Saf (2008) 0.93
P53 mutation analysis of colorectal liver metastases: relation to actual survival, angiogenic status, and p53 overexpression. Clin Cancer Res (2005) 0.93
Comparison of effects of VDR versus PXR, FXR and GR ligands on the regulation of CYP3A isozymes in rat and human intestine and liver. Eur J Pharm Sci (2009) 0.93
Extrahepatic bile duct resection in combination with liver resection for hilar cholangiocarcinoma: a report of 42 cases. J Gastrointest Surg (2004) 0.93
Hepatic expression of ABC transporters G5 and G8 does not correlate with biliary cholesterol secretion in liver transplant patients. Hepatology (2005) 0.91
Established and new-generation antithrombotic drugs in patients with cirrhosis - possibilities and caveats. J Hepatol (2013) 0.90
Regeneration of human extrahepatic biliary epithelium: the peribiliary glands as progenitor cell compartment. Liver Int (2011) 0.90
Altered bile composition after liver transplantation is associated with the development of nonanastomotic biliary strictures. J Hepatol (2008) 0.90
Rapid increase of bile salt secretion is associated with bile duct injury after human liver transplantation. J Hepatol (2004) 0.90
Rodent nutritional model of steatohepatitis: effects of endotoxin (lipopolysaccharide) and tumor necrosis factor alpha deficiency. J Gastroenterol Hepatol (2006) 0.90
The sequence of revascularization in liver transplantation: it does make a difference. Liver Transpl (2006) 0.89
Aprotinin and nafamostat mesilate in liver surgery: effect on blood loss. Dig Surg (2007) 0.89
Surgical injuries of postmortem donor livers: incidence and impact on outcome after adult liver transplantation. Liver Transpl (2006) 0.89
Epidemiology and clinical characteristics of autoimmune hepatitis in the Netherlands. Scand J Gastroenterol (2014) 0.88
Bile salt toxicity aggravates cold ischemic injury of bile ducts after liver transplantation in Mdr2+/- mice. Hepatology (2006) 0.88
Hypercoagulability as a contributor to thrombotic complications in the liver transplant recipient. Liver Int (2013) 0.88
Duct-to-duct reconstruction in liver transplantation for primary sclerosing cholangitis is associated with fewer biliary complications in comparison with hepaticojejunostomy. Liver Transpl (2014) 0.87
Liver transplantation for unresectable hepatocellular carcinoma in patients without liver cirrhosis. Transpl Int (2010) 0.87
Expression and regulation of the bile acid transporter, OSTalpha-OSTbeta in rat and human intestine and liver. Biopharm Drug Dispos (2009) 0.87
Hepatic hemangiosarcoma: an absolute contraindication to liver transplantation--the European Liver Transplant Registry experience. Transplantation (2013) 0.87
Activation and regulation of hemostasis in acute liver failure and acute pancreatitis. Semin Thromb Hemost (2010) 0.87
The origin of biliary strictures after liver transplantation: is it the amount of epithelial injury or insufficient regeneration that counts? J Hepatol (2013) 0.86
Graft loss after pediatric liver transplantation. Ann Surg (2002) 0.85
The role of bile salt toxicity in the pathogenesis of bile duct injury after non-heart-beating porcine liver transplantation. Transplantation (2008) 0.85
Prevalence of psychological problems and associated transplant-related variables at different time periods after liver transplantation. Liver Transpl (2015) 0.85
The role of platelets in liver inflammation and regeneration. Semin Thromb Hemost (2010) 0.85
Plasma MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 during human orthotopic liver transplantation. The effect of aprotinin and the relation to ischemia/reperfusion injury. Thromb Haemost (2004) 0.85
JC virus infection in colorectal neoplasia that develops after liver transplantation. Clin Cancer Res (2008) 0.85
Antifibrinolytics in liver transplantation: they are effective, but what about the risk-benefit ratio? Liver Transpl (2004) 0.84
The platelet and platelet function testing in liver disease. Clin Liver Dis (2009) 0.84
Cytomegalovirus infection increases the risk for inflammatory bowel disease. Am J Pathol (2010) 0.84
The impact of hepatic steatosis on liver regeneration after partial hepatectomy. Liver Int (2013) 0.84
Orthotopic liver transplantation for portosystemic encephalopathy in an adult with congenital absence of the portal vein. Liver Transpl (2004) 0.84
Mannose-binding lectin and ficolin-2 gene polymorphisms predispose to cytomegalovirus (re)infection after orthotopic liver transplantation. J Hepatol (2011) 0.83
Recombinant factor VIIa in orthotopic liver transplantation: influence on parameters of coagulation and fibrinolysis. Blood Coagul Fibrinolysis (2003) 0.83
Partial external biliary diversion in children with progressive familial intrahepatic cholestasis and Alagille disease. J Pediatr Gastroenterol Nutr (2009) 0.83
Inflammation mediated down-regulation of hepatobiliary transporters contributes to intrahepatic cholestasis and liver damage in murine biliary atresia. Pediatr Res (2009) 0.83
Biliary complications after orthotopic liver transplantation. Curr Opin Organ Transplant (2014) 0.82
A benefit-risk review of systemic haemostatic agents: part 2: in excessive or heavy menstrual bleeding. Drug Saf (2008) 0.82
Honoring the contract with our patients: outcome after repeated re-transplantation of the liver. Clin Transplant (2010) 0.82
The role of recombinant factor VIIa in liver transplantation. Liver Transpl (2005) 0.82
Aprotinin and thromboembolism in liver transplantation: is there really a causal effect? Anesth Analg (2002) 0.82
Spatiotemporal expression of heme oxygenase-1 detected by in vivo bioluminescence after hepatic ischemia in HO-1/Luc mice. Liver Transpl (2006) 0.81
The effect of HLA mismatches, shared cross-reactive antigen groups, and shared HLA-DR antigens on the outcome after pediatric liver transplantation. Liver Transpl (2005) 0.81
[Intra-articulair tibial Plateau Fractures]. Z Orthop Unfall (2017) 0.81
Oxygenated Hypothermic Machine Perfusion After Static Cold Storage Improves Hepatobiliary Function of Extended Criteria Donor Livers. Transplantation (2016) 0.80
Routine coagulation assays underestimate levels of antithrombin-dependent drugs but not of direct anticoagulant drugs in plasma from patients with cirrhosis. Br J Haematol (2013) 0.80
Sequential and simultaneous revascularization in adult orthotopic piggyback liver transplantation. Liver Transpl (2005) 0.80
Place of liver transplantation in the treatment of hepatocellular carcinoma in the normal liver. Liver Transpl (2011) 0.80